^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

locnartecan (PEN-866)

i
Associations
Company:
Madrigal Pharma, National Cancer Institute - Bethesda, SciClone, Tarveda Therap
Drug class:
Topoisomerase I inhibitor, HSP90 inhibitor
Related drugs:
Associations
Phase 1/2
National Cancer Institute (NCI)
Recruiting
Last update posted :
02/20/2025
Initiation :
10/31/2024
Primary completion :
02/28/2026
Completion :
12/31/2026
UGT1A1
|
UGT1A1*28 • UGT1A1*1*1
|
temozolomide • vincristine • locnartecan (PEN-866)
Phase 1/2
Tarveda Therapeutics
Recruiting
Last update posted :
02/17/2022
Initiation :
08/29/2017
Primary completion :
01/01/2023
Completion :
06/01/2023
HSP90AA1
|
5-fluorouracil • Zejula (niraparib) • irinotecan • leucovorin calcium • locnartecan (PEN-866)